Knowing the activation idea of the PDGFβ gene, and also of the substances that block certain phases from the activation of this gene, a specific therapy for the protuberant dermatofibrosarcoma is prefigured. This evidence concerns the gene PDGFB and dermatofibrosarcoma protuberans.